Sign in Subscribe
United States. Securities and Exchange Commission

Regen Biopharma Inc. Files SEC Filing of Form 8-K on March 24, 2015

Strategic Insights

— 1 min read

Regen Biopharma Inc., a publicly traded company in the pharmaceutical preparations industry, filed a significant document with the U.S. Securities and Exchange Commission (SEC) on March 24, 2015. The filing, designated as Form 8-K, reported material events and corporate changes that were not previously disclosed to investors or security holders. As a notable pharmaceutical company, Regen Biopharma's filing likely garnered attention from industry observers and investors.

Key Takeaways:

  • The SEC filing, Form 8-K, was submitted by Regen Biopharma Inc. on March 24, 2015, which falls under the SIC code 2834, Pharmaceutical Preparations.
  • The company's contact information, as listed in the SEC filing, includes an address at 4700 SPRING ST #304, LA MESA CA 91942, and a phone number of 619-702-1404.
  • Form 8-K serves as a current report for material events or corporate changes, providing more up-to-date information than forms 10-Q or 10-K.
  • The filing is a formal document submitted to the SEC, detailing corporate events and changes relevant to investors and security holders.
  • Regen Biopharma Inc.'s filing is accessible through the SEC's website at http://www.sec.gov/Archives/edgar/data/1589150/0001607062-15-000127-index.html.
  • Keywords associated with this news article include "Pharmaceutical Preparations," "SEC Filing," and "Regen Biopharma Inc."

Statistics:

  • The SEC filing was made on March 24, 2015 (Source: SEC Form 8-K filing)
  • The company's address is listed as 4700 SPRING ST #304, LA MESA CA 91942 (Source: SEC Form 8-K filing)
  • The phone number associated with the company is 619-702-1404 (Source: SEC Form 8-K filing)
  • Form 8-K filings report material events and corporate changes (Source: SEC.org)
  • Regen Biopharma Inc.'s filing can be accessed through the SEC website at http://www.sec.gov/Archives/edgar/data/1589150/0001607062-15-000127-index.html.

Sources:

  • U.S. Securities and Exchange Commission (SEC)
  • Regen Biopharma Inc. Form 8-K filing (http://www.sec.gov/Archives/edgar/data/1589150/0001607062-15-000127-index.html)
  • NewsRx LLC (Copyright 2015)

Read more